| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 453,956 | 382,990 | 405,666 | 637,949 | | Cost of Revenue | 287,352 | 253,509 | 280,931 | 427,536 | | | Gross Profit | 166,604 | 129,481 | 124,735 | 210,413 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 129,897 | 124,766 | 136,257 | 173,065 | | Non Recurring | 4,440 | 3,878 | 5,085 | 21,515 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,267 | 837 | (16,607) | 15,833 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 125 | 135 | 326 | | Earnings Before Interest And Taxes | 32,318 | 962 | (16,472) | 16,159 | | Interest Expense | 3,167 | 3,049 | 3,198 | 4,384 | | Income Before Tax | 29,151 | (2,087) | (19,670) | 11,775 | | Income Tax Expense | 11,441 | (695) | (7,802) | 3,252 | | Minority Interest | (96) | (5) | (18) | (8) | | | | Net Income From Continuing Ops | 17,614 | (1,397) | (11,886) | 8,515 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,614 | (1,397) | (11,886) | 8,515 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,614 | ($1,397) | ($11,886) | $8,515 |
|
0.11% Nasdaq 
0.01%
Income Statement
